KiranMusunuruMD
Cardiology • Philadelphia, PAAdult Congenital Heart Disease
Associate Professor, Medicine - Perelman School of Medicine at the University of Pennsylvania
Dr. Musunuru is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd, Bldg 421
11-104 Smilow Center for Translational Research
Philadelphia, PA 19104
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2006 - 2009
Brigham and Women's HospitalResidency, Internal Medicine, 2004 - 2006
Weill Cornell MedicineClass of 2004
Certifications & Licensure
PA State Medical License 2017 - 2024
MA State Medical License 2008 - 2017- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Grounded in Reality: Integrating Community Values and Priorities of End Users in Human Gene Editing.Kirsten A Riggan, Roel Feys, Assata Kokayi, Karen M Meagher, Marsha Michie
The American Journal of Bioethics. 2024-08-01 - Response to Harding and Martinez.Dominique L Brooks, Kiran Musunuru, Xiao Wang
HGG Advances. 2024-07-18 - An epigenetic editor to silence genes.Madelynn N Whittaker, Kiran Musunuru
Science. 2024-06-28
Journal Articles
- In Utero CRISPR-Mediated Therapeutic Editing of Metabolic GenesWilliam H Peranteau, Philip W Zoltick, Kiran Musunuru, William Zacharias, Nature
- Author Correction: Regulatory Variants at KLF14 Influence Type 2 Diabetes Risk via a Female-Specific Effect on Adipocyte Size and Body CompositionCalvin Pan, Kiran Musunuru, Avanthi Raghavan, Nature
- Circular Non-Coding RNA ANRIL Modulates Ribosomal RNA Maturation and Atherosclerosis in HumansKiran Musunuru, MD, Nature
Press Mentions
Gene-Editing Therapy Reduced Attacks in Hereditary AngioedemaOctober 24th, 2024- Experts Agree Intravenous Iron Shows Promise for Heart Failure PatientsNovember 7th, 2022
- CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin AmyloidosisNovember 5th, 2022
- Join now to see all
Grant Support
- Genetic And Functional Analyses Of A Novel Locus Associated With LDL-C And MINational Heart, Lung, And Blood Institute2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
